나노엔텍

039860KOSDAQ의료용 기기 제조업

50.3 / 100

Reference Date: 2026-06-10

Financial Score18.0 / 40

News Sentiment18.3 / 25

Momentum4.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Plunged 30.1% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

NanoEntek develops, manufactures, and sells in vitro diagnostic medical devices and life science experiment equipment based on the Lab-On-a-Chip (LOC) platform. The company leverages its core Bio-MEMS technology, integrating microfluidics and nanotechnology, to enable applications in cancer diagnostics, cell counting, and other fields. It operates a U.S. sales subsidiary and a B2B healthcare service arm, expanding its global market presence.

Number of Employees

141people

Average Salary

53.2M KRW

Score Calculation Basis

Detailed Financial Score

PER

93.19Industry Average 21.510.0Point

4.3x industry avg (risky)

PBR

1.83Industry Average 1.382.5Point

Higher than industry avg (caution)

ROE

1.92Industry Average 8.001.0Point

Well below industry avg

Debt Ratio

1.76Industry Average 11.658.0Point

Half of industry avg (excellent)

Trend 2023~20256.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲19.3% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲102.6% (2-year basis)

ROE Trend

1.0 / 4

Avg ROE 0.3% (improving, 3yr)

Detailed News Sentiment

3 totalPositive 2Neutral 1Negative 0Average Sentiment Score 73.3

Positive
나노엔텍, 차세대 유전자 전달장비 대용량 모델 개발 착수…"CGT 생산...
나노엔텍이 대용량 유전자 전달 장비 개발로 CGT 생산 시장 경쟁력 강화.
Neutral
3CE·닥터지 품에 안은 로레알…“한국은 혁신 파트너” [글로벌 K뷰티...
글로벌 뷰티 기업 로레알의 K뷰티 협력 확대 소식은 간접적 영향을 미치나, 나노엔텍의 직접적인 관련성이 낮아 중립적 평가.
Positive
나노엔텍, 1분기 매출 32%↑…“2분기 바이오로봇 공급 확대 기대”
나노엔텍의 1분기 매출이 전년 동기 대비 31.7% 증가하며 성장세를 이어가고 있어 긍정적 전망이 제기됩니다.

Detailed Momentum

52-week position3.0Point

52w lower range (29%)

Current 4,380Won52-week high 7,67052-week low 3,030

1-month return0.0Point

1m -30.14% (strong drop)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

4 totalPositive 0Neutral 4Negative 0

Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-05-29
Neutral임시주주총회결과2026-05-29
Neutral분기보고서 (2026.03)2026-05-15
Neutral주주총회소집공고2026-05-14